Status:
COMPLETED
HbA2 Leuven and Its Impact on HbA1c Results
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Family Study HbA2 Leuven Mutation.
Eligibility:
All Genders
Phase:
NA
Brief Summary
The study is designed to demonstrate HbA2 Leuven mutation and to asssess its impact on routine HbA1c measurements.
Detailed Description
HbA2 Leuven mutation will be investigated using molecular diagnostic techniques. Interference on HbA1c measurements will be assessed in HbA2 Leuven carriers using different methodologies.
Eligibility Criteria
Inclusion
- Family history of HbA2 Leuven mutation.
Exclusion
- Any condition inhibiting simple blood withdrawal.
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01909648
Start Date
September 1 2013
End Date
February 1 2014
Last Update
July 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZLeuven
Leuven, Belgium